Literature DB >> 18090164

Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.

Arthur L Berman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18090164     DOI： 10.1097/01.mcg.0000225685.37465.e7

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  10 in total

Review 1.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

2.  Rifaximin for the treatment of acute infectious diarrhea.

Authors:  Kyoung Sup Hong; Joo Sung Kim
Journal:  Therap Adv Gastroenterol       Date:  2011-07       Impact factor: 4.409

Review 3.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

4.  Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection.

Authors:  Muhammad Waqas; Khadija Mohib; Aniqa Saleem; Mahak Lnu; Sabeen Arjumand; Hafiz Habib Ur Rehman Khalil; Rukhshanda Nosheen; Sharmeen Abbas; Kanza M Maqsood; Kiran Abbas
Journal:  Cureus       Date:  2022-04-14

Review 5.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

Review 6.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

7.  Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study.

Authors:  David T Rubin; Sunana Sohi; Matthew Glathar; Tojo Thomas; Nicole Yadron; Bonnie L Surma
Journal:  Gastroenterol Res Pract       Date:  2011-11-09       Impact factor: 2.260

8.  Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin.

Authors:  Dominador Lao; Tom Chiang; Eric Gomez
Journal:  Case Rep Med       Date:  2012-07-09

9.  New advances in the treatment of Clostridium difficile infection (CDI).

Authors:  Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

10.  Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Yang Song; Shashank Garg; Mohit Girotra; Cynthia Maddox; Erik C von Rosenvinge; Anand Dutta; Sudhir Dutta; W Florian Fricke
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.